Investors shift focus from gene therapy to lucrative weight-loss drugs ...Middle East

A researcher works in Dr. John Tisdale's lab at the National Institutes of Health after the agency announced a breakthrough in sickle cell anemia research in Bethesda, US on March 11, 2019. — ReutersGene therapy, which promises a possible cure for rare diseases like sickle cell, is...

Read More Details
Finally We wish PressBee provided you with enough information of ( Investors shift focus from gene therapy to lucrative weight-loss drugs )

Also on site :

• New York reports record pediatric flu deaths this season
• On Your Plate, In Your Brain: These Foods May Speed Up Parkinson’s Symptoms
• Day Two of Cardinal Conclave: The World Awaits a New Pope